341 related articles for article (PubMed ID: 18504409)
1. HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
Kagami S; Kanari H; Suto A; Fujiwara M; Ikeda K; Hirose K; Watanabe N; Iwamoto I; Nakajima H
Int Arch Allergy Immunol; 2008; 146 Suppl 1():61-6. PubMed ID: 18504409
[TBL] [Abstract][Full Text] [Related]
2. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells.
Chiba N; Masuda A; Yoshikai Y; Matsuguchi T
J Cell Physiol; 2007 Oct; 213(1):126-36. PubMed ID: 17458900
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Yokota K; Miyazaki T; Hirano M; Akiyama Y; Mimura T
J Rheumatol; 2006 Mar; 33(3):463-71. PubMed ID: 16511915
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
5. High dosage of simvastatin reduces TNF-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1beta in vitro.
Henrich D; Seebach C; Wilhelm K; Marzi I
J Surg Res; 2007 Sep; 142(1):13-9. PubMed ID: 17716606
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin induces interleukin-18 production in human peripheral blood mononuclear cells.
Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Nishibori M
Clin Immunol; 2005 Sep; 116(3):211-6. PubMed ID: 15936988
[TBL] [Abstract][Full Text] [Related]
7. Hydroxymethylglutaryl--CoA reductase inhibitor inhibits induction of nitric oxide synthase in 3T3--L1 preadipocytes.
Dobashi K; Araki S; Kubo K; Kawagoe R; Yamamoto Y; Shirahata A
Life Sci; 2008 Jan; 82(1-2):85-90. PubMed ID: 18036617
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin attenuates lipopolysaccharide-induced airway mucus hypersecretion in rats.
Ou XM; Wang BD; Wen FQ; Feng YL; Huang XY; Xiao J
Chin Med J (Engl); 2008 Sep; 121(17):1680-7. PubMed ID: 19024099
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide.
Li JJ; Chen XJ
Coron Artery Dis; 2003 Jun; 14(4):329-34. PubMed ID: 12826933
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid-binding protein regulates LPS-induced TNF-alpha production in mast cells.
Yamamoto N; Kaneko I; Motohashi K; Sakagami H; Adachi Y; Tokuda N; Sawada T; Furukawa H; Ueyama Y; Fukunaga K; Ono M; Kondo H; Owada Y
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):21-6. PubMed ID: 18678477
[TBL] [Abstract][Full Text] [Related]
11. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
Hu WL; Qiao SB; Li JJ
Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
[TBL] [Abstract][Full Text] [Related]
12. Statin treatment and 3' polyadenylation of eNOS mRNA.
Kosmidou I; Moore JP; Weber M; Searles CD
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2642-9. PubMed ID: 17916773
[TBL] [Abstract][Full Text] [Related]
13. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effect of simvastatin on interferon-beta-induced expression of CC chemokine ligand 5 in microglia.
Nakamichi K; Saiki M; Kitani H; Kuboyama Y; Morimoto K; Takayama-Ito M; Kurane I
Neurosci Lett; 2006 Oct; 407(3):205-10. PubMed ID: 16978784
[TBL] [Abstract][Full Text] [Related]
15. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4.
Gondokaryono SP; Ushio H; Niyonsaba F; Hara M; Takenaka H; Jayawardana ST; Ikeda S; Okumura K; Ogawa H
J Leukoc Biol; 2007 Sep; 82(3):657-65. PubMed ID: 17575266
[TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells.
Marshall JS; Leal-Berumen I; Nielsen L; Glibetic M; Jordana M
J Clin Invest; 1996 Feb; 97(4):1122-8. PubMed ID: 8613537
[TBL] [Abstract][Full Text] [Related]
17. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis.
Tanaka T; Porter CM; Horvath-Arcidiacono JA; Bloom ET
Int Immunol; 2007 Feb; 19(2):163-73. PubMed ID: 17182966
[TBL] [Abstract][Full Text] [Related]
18. Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts.
Wax S; Piecyk M; Maritim B; Anderson P
Arthritis Rheum; 2003 Feb; 48(2):541-50. PubMed ID: 12571865
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin stimulates macrophage interleukin-1beta secretion through an isoprenylation-dependent mechanism.
Lindholm MW; Nilsson J
Vascul Pharmacol; 2007 Feb; 46(2):91-6. PubMed ID: 16942919
[TBL] [Abstract][Full Text] [Related]
20. Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1.
Kuijk LM; Mandey SH; Schellens I; Waterham HR; Rijkers GT; Coffer PJ; Frenkel J
Mol Immunol; 2008 Apr; 45(8):2158-65. PubMed ID: 18242710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
